Milestone Pharmaceuticals Inc. - Common Shares (MIST)

Q4 2019 13F Holders as of 12/31/2019

Type / Class: Equity / Common Shares
Shares outstanding: 89.4M
Number of holders: 23
Total 13F shares, excl. options: 14.4M
Shares change: +1.31M
Total reported value, excl. options: $230M
Value change: +$20.2M
Number of buys: 11
Number of sells: -7
Price: $16.01

Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q4 2019

26 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares as of Q4 2019.
Milestone Pharmaceuticals Inc. - Common Shares (MIST) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.4M shares of 89.4M outstanding shares and own 16.09% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.96M shares), Novo Holdings A/S (2.43M shares), VHCP Management III, LLC (2.07M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.29M shares), BOXER CAPITAL, LLC (1.1M shares), Tekla Capital Management LLC (747K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (600K shares), ACUTA CAPITAL PARTNERS, LLC (509K shares), ORBIMED ADVISORS LLC (364K shares), and Invesco Ltd. (322K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.